Adherence to Guidelines-Based Management of Non-Muscle Invasive Bladder Cancer Among Society of Urologic Oncology (SUO) Members - Justin T. Matulay ...

(UroToday.com) Dr. Sean Elliott, Professor of Urology at the University of Minnesota, delivered a comprehensive and informative presentation addressing the evolving role of urologists in genitourinary ...

Patient Out-of-Pocket Costs for Guideline-Recommended Treatments for Erectile Dysfunction: A Medicare Cost Modeling Analysis - Beyond the Abstract ...

(UroToday.com) Sunday afternoon’s plenary session continued with an insightful talk by Dr. José Carlos Truzzi from the Federal University of Sao Paulo. Dr. Truzzi began the session with a brief ...

Chicago, IL (UroToday.com) STAMPEDE arm H assessed the efficacy of radiotherapy to the primary in M1 disease 1. This study randomized 2,061 to either standard systemic treatments (ADT +/- chemotherapy ...

When Should We Use 18F-FDG PET? "Presentation" - Andrei Iagaru ...

Prospective Monitoring of Prostate Specific Membrane Antigen (PSMA) –Positive Recurrent Prostate Cancer: Preliminary Data from 6 Months PSMA Follow-Up. Ravi A. Madan, MD Preliminary data from the ...

Condition: Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Unresectable Renal Cell Carcinoma Study ID: NCT05327686 ...

He describes a 67-year-old man with recurrent T1 disease after BCG who refused cystectomy despite high-risk features including lymphovascular invasion. Dr. Tyson outlines multiple treatment options ...

Background: The incidence of bladder cancer was estimated at 61,420 in the United States in 2006, and the rate is increasing with the aging population. Studies have shown that 6% to 12% of hematuria ...

Telehealth and direct-to-consumer healthcare platforms have reshaped the way patients interact with healthcare systems, especially regarding sensitive conditions such as erectile dysfunction (ED) and ...